Hermes Biosciences Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Seed

  • Investors
  • 4

Hermes Biosciences General Information

Description

Developer of benchtop extracellular vesicle isolation technology intended to purify exosomes from bodily fluids and cell culture media. The company processes samples directly, and provides reproducible, efficient purification of extracellular vesicles, enabling researchers in oncology, degenerative disease, and regenerative medicine fields to study exosome functions and their potential therapeutic uses.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 61 Airport Boulevard
  • Suite D, South
  • San Francisco, CA
  • United States
+1 (650)
Primary Industry
Diagnostic Equipment
Other Industries
Discovery Tools (Healthcare)
Vertical(s)
Corporate Office
  • 61 Airport Boulevard
  • Suite D, South
  • San Francisco, CA
  • United States
+1 (650)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hermes Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 18-Nov-2025 Completed Startup
1. Seed Round Completed Startup
To view Hermes Biosciences’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Hermes Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hermes Biosciences Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Genoa Ventures Venture Capital Minority
Paladin Capital Group Venture Capital Minority
Vertical Venture Partners Venture Capital Minority
General Inception Venture Capital Minority
To view Hermes Biosciences’s complete investors history, request access »

Hermes Biosciences FAQs

  • When was Hermes Biosciences founded?

    Hermes Biosciences was founded in 2024.

  • Where is Hermes Biosciences headquartered?

    Hermes Biosciences is headquartered in San Francisco, CA.

  • What is the size of Hermes Biosciences?

    Hermes Biosciences has 7 total employees.

  • What industry is Hermes Biosciences in?

    Hermes Biosciences’s primary industry is Diagnostic Equipment.

  • Is Hermes Biosciences a private or public company?

    Hermes Biosciences is a Private company.

  • What is Hermes Biosciences’s current revenue?

    The current revenue for Hermes Biosciences is .

  • Who are Hermes Biosciences’s investors?

    Genoa Ventures, Paladin Capital Group, Vertical Venture Partners, and General Inception have invested in Hermes Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process